Table 1.

Incidence of uveitis and peak disease score of mice after untreated antigen-presenting cells (APC) versus tolerogenic antigen-presenting cell (TolAPC) treatment.

Treatment of EAU mice	Incidence of mice with clinical score ≥2	Peak disease score ± s.e.m.
Untreated APC	9/14	2·0 ± 0·026
Tolerogenic APC	0/14*	0·64 ± 0·13*

Scores are from the experimental and control mice used for Fig. 2.

^*Indicates a significant difference (P ≤ 0·05) between untreated and TolAPC-treated mice. EAU: experimental autoimmune uveitis; s.e.m.: standard error of the mean.